Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®

PURPOSE: The chimeric monoclonal antibody (mAb) chDAB4 (APOMAB®) targets the Lupus associated (La)/Sjögren Syndrome-B (SSB) antigen, which is over-expressed in tumors but only becomes available for antibody binding in dead tumor cells. Hence, chDAB4 may be used as a novel theranostic tool to disting...

Descripción completa

Detalles Bibliográficos
Autores principales: Liapis, Vasilios, Tieu, William, Rudd, Stacey E., Donnelly, Paul S., Wittwer, Nicole L., Brown, Michael P., Staudacher, Alexander H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672150/
https://www.ncbi.nlm.nih.gov/pubmed/33205364
http://dx.doi.org/10.1186/s41181-020-00109-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672150/
https://www.ncbi.nlm.nih.gov/pubmed/33205364
http://dx.doi.org/10.1186/s41181-020-00109-6

Ejemplares similares